Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

UBS Upgrades China Stocks Amid 'Valuation Collapse': What Investors Need to Know

Published 23/04/2024, 20:20
© Reuters.  UBS Upgrades China Stocks Amid 'Valuation Collapse': What Investors Need to Know

Benzinga - by Surbhi Jain, .

In a surprising turn of events, UBS Group AG has made a rare upgrade call, lifting its recommendation on a key Chinese stock index to Overweight.

As of 2 p.m. ET, Chinese equity tracking ETFs such as the iShares China Large-Cap ETF (NYSE:FXI) was trading up 1.52%, KraneShares CSI China Internet ETF (NYSE:KWEB) was up 2.86%, and iShares MSCI China ETF (NASDAQ:MCHI) was up 1.26%.

Stocks of Chinese companies also shared in the optimism with Alibaba Group Holding (NYSE:BABA) (OTC:BABAF) was up 2.65%, PDD Holdings (NASDAQ:PDD) up 2.87%, Tencent Holdings ADR (OTC:TCEHY) up 3.51%, Li Auto Inc (NASDAQ:LI) up 0.24%, XPeng (NYSE:XPEV) up 2.29%, NIO – ADR (NYSE:NIO) up 2.50%, and JD.com (NASDAQ:JD) up 2.06%.

UBS Analyst Upgrades China To Overweight This move comes amidst a backdrop of lingering concerns over China’s property sector and broader macroeconomic worries. However, Sunil Tirumalai, UBS' institutional research Global Emerging Markets equity strategist, pointed to resilient earnings as a beacon of hope in an otherwise turbulent market.

Among the tailwinds highlighted by UBS that support the bullish outlook for Chinese stocks were:

  • Interventions from state-related funds.
  • Positive surprises in dividends and buybacks from local firms.
  • Underperformance Attributable To “Valuation Collapse” According to Tirumalai, the underperformance of China stocks can be attributed solely to a “valuation collapse,” reported CNBC. He emphasized that the largest stocks in the China index have maintained strong earnings and fundamentals, providing a solid foundation for future growth.

    To this end, KraneShares’ CIO Brendan Ahern, noted his team’s perspective on China and emerging markets fundamentals differs from conventional views.

    3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

    The company believes sector dysfunction in emerging markets and China indices is driving underperformance, particularly due to the large weight of value sectors. Conventional index construction methods, while useful for financial analysis, pose challenges for forecasting.

    Stocks with higher P/E ratios have a disproportionately lower weight in earnings per share (EPS), leading to forecasting difficulties. As a result, movements in higher P/E stocks dominate index performance, while EPS is influenced more by lower P/E stocks.

    China’s Stock Market: A Potentially Rare Opportunity In a recent exclusive interview with Benzinga, Henry Greene, investment strategist at KraneShares pointed out, “China’s stock market has bottomed, indicating a potentially rare opportunity.”

    We covered his insights here: EXCLUSIVE: ‘China’s Stock Market Has Bottomed, Indicating A Potentially Rare Opportunity,’ Says Investment Strategist

    Later, in another exclusive, with Benzinga, Ahern shared “the long-term trend of China investing heavily in developing its domestic chip capabilities and reducing reliance on foreign suppliers.”

    The upgrade appeared to fall in line with KraneShares philosophy and outlook toward Chinese equity.

    Despite concerns over geopolitical tensions and regulatory uncertainties, Chinese equities have shown signs of resilience, with both the MSCI China Index and the Hang Seng Index posting double-digit gains in recent months.

    While risks remain, including heightened geopolitical noise, UBS’s upgrade underscored a growing sense of confidence in China’s economic recovery.

    As investors navigate these uncertain times, UBS’s bold call serves as a reminder of the potential opportunities ahead in the Chinese market.

    Read Next: EXCLUSIVE: KraneShares CIO Talks Intel And AMD, As China Seeks Semiconductor Self-Sufficiency

    3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

    Photo: Shutterstock

    © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    Read the original article on Benzinga

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.